Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT06704308 for HPV Vaccination is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Parents' HPV Stories 58 Vaccine Study
Clinical Trial NCT06704308 is an interventional study for HPV Vaccination and is currently not yet recruiting. Enrollment is planned to begin on 1 February 2026 and continue until the study accrues 58 participants. Led by Anne E Ray, this study is expected to complete by 1 November 2026. The latest data from ClinicalTrials.gov was last updated on 10 December 2025.
Brief Summary
The goal of this clinical trial is to evaluate the feasibility of intervention implementation in two clinics in rural KY, and its preliminary efficacy with regards to increasing vaccine confidence in a sample of vaccine hesitant parents.
Hypothesis: Parents will report increased vaccine confidence scores post-intervention.
Data from this study will provide preliminary data for a larger scale evaluation of the inter...
Show MoreDetailed Description
Participants will be asked to complete a brief screening assessment to establish their eligibility for participation. Eligible participants will be asked to complete a consent form and be directed to the pre-test survey. Upon completion of the survey, the participants will be directed to the tailored intervention content, including the Parents' Stories videos. This step will be completed prior to interaction with the...Show More
Official Title
Development and Preliminary Evaluation of a Multilevel Intervention to Increase HPV Vaccine Confidence Among Parents of Youth in Rural KY
Conditions
HPV VaccinationOther Study IDs
- 95632
NCT ID Number
Start Date (Actual)
2026-02
Last Update Posted
2025-12-10
Completion Date (Estimated)
2026-11
Enrollment (Estimated)
58
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Primary Purpose
Prevention
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalParents' Stories Web Application + Provider Elaborated Prompts Participating parents will be asked to navigate a web application that consists of (a) brief, 90-second narrative videos that encourage parent-provider communication about the vaccine and (b) personalized feedback to parents that is tailored to provide educational content in response to their concerns and be motivational in nature. Providers will provide elaborated prompts related to the vaccine when meeting with par...Show More | Web Application A web application for vaccine-hesitant parents and their teens with brief, 90-second narrative videos and tailored, motivational content Provider Elaborated Prompts A component for providers that suggests elaborated prompts to be used with parents that align with the content of the web application, are tailored to parent concerns, and are motivational in nature |
Primary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Change in HPV Vaccine Hesitancy Scale score | 9-item scale from Strongly Disagree (1) to Strongly Agree (5); scores range from 1-5, with higher scores indicating greater hesitancy | From pretest to posttest (up to two weeks) |
Change Human Papillomavirus Knowledge Questionnaire score | 13-item scale with True / False / I don't know response options; scores range from 0-13 with higher scores indicating greater vaccine knowledge | From pretest to posttest (up to two weeks) |
Change in intent to discuss HPV vaccine with provider | Answers include Very likely; Somewhat likely; Not too likely; Not likely at all; Not sure / do not know | From pretest to posttest (up to two weeks) |
Change in HPV vaccine intent | 1 item adapted from NIS-TEEN survey. Answers include very likely; somewhat likely; not too likely; not likely at all; not sure / do not know | From pretest to posttest (up to two weeks) |
Change in self-reported HPV vaccination and related provider recommendations | 4 items adapted from the NIS-TEEN survey. | from screening to posttest (up to two weeks) |
Change in Reasons Not to Vaccinate score | 16 items adapted from NIS-TEEN survey; higher score indicates more obstacles to vaccination | Pretest only |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
Female
Accepts Healthy Volunteers
Yes
- status as a mother or female guardian of an 11-17-year-old adolescent
- status as a U.S. resident
- self-reported ability to read English
- self-reported HPV vaccine hesitant using established methodology
-
Anne E Ray- Real Prevention, LLC
- Merck Institute for Therapeutic Research707 active studies to explore
Study Responsible Party
Anne E Ray, Sponsor-Investigator, Associate Professor, University of Kentucky
Study Central Contact
Contact: Anne E Ray, PhD, 859-218-4944, [email protected]
1 Study Locations in 1 Countries
Kentucky
University of Kentucky, Lexington, Kentucky, 40506, United States
Anne E Ray, PhD, Contact, 859-218-4944, [email protected]